TITLE

OTHER ARTICLES NOTED

PUB. DATE
January 2005
SOURCE
ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on articles published in this issue of the periodical. All articles that meet criteria in the reviewed journals are cited in the periodical, but there is not enough space to abstract them all. The following articles passed all criteria but were not abstracted because, in the judgment of editors, their findings were less widely applicable to clinical practice in internal medicine. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment, randomised controlled trial.
ACCESSION #
15851804

 

Related Articles

  • Treatment effects monitoring committees and early stopping in large clinical trials. Kiri, Antariksha; Tonascia, Susan; Meinert, Curtis L. // Clinical Trials;2004, Vol. 1 Issue 1, p40 

    Background Treatment effects monitoring is a process carried out over the course of a trialto determine whether it should continue unaltered. The purpose of monitoring is to protect persons enrolled from harm, caused either by exposure to an ineffective or harmful treatment or failure to provide...

  • The Journal Impact Factor as a Predictor of Trial Quality and Outcomes: Cohort Study of Hepatobiliary Randomized Clinical Trials. Gluud, Lise L.; Sørensen, Thorkild I. A.; Gøtzsche, Peter C.; Gluud, Christian // American Journal of Gastroenterology;Nov2005, Vol. 100 Issue 11, p2431 

    OBJECTIVES: To examine the association between the impact factor and characteristics of hepatobiliary randomized clinical trials. METHODS: A cohort study of 530 hepatobiliary randomized clinical trials was performed. The journal impact factor was extracted from Science Citation Index. For each...

  • The nature of clinical trials in nephrology.  // Kidney International;Nov1992, Vol. 42 Issue 5, p1061 

    The article reflects the opinion of the author on the manner in which cooperative trials might be organized in relation to nephritides. The author addressed glomerulopathies as an example for clinical trials, not because it is a major cause of renal morbidity and mortality, but because the...

  • Acupuncture for migraine (n=960). Cummings, Mike // Acupuncture in Medicine;Dec2006, Vol. 24 Issue 4, p188 

    An abstract of the article "Efficacy of Acupuncture for the Prophylaxis of Migraine: A Multicentre Randomised Controlled Clinical Trial" is presented. This study has compared the clinical result between acupuncture with minimal acupuncture and standard medication in treating migraine. The...

  • Applied Clinical Trials on the Web: www.actmagazine.com.  // Applied Clinical Trials;Oct2005, Vol. 14 Issue 10, p16 

    Features the web site of the periodical "Applied Clinical Trials." Several issues of the magazine; Survey on issues relating to the clinical trials industry; Listing of articles, including graphics and charts; Listing of events.

  • PURPOSE AND PROCEDURE.  // Evidence Based Medicine;May2003, p66 

    The article discusses the purpose and procedure of the journal to alert practitioners on the important advances in internal medicine, family practice, surgery, psychiatry, pediatrics, and obstetrics. It details the procedures and criteria for review and selection from English language original...

  • Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations. Kr�tz, Florian; Sohn, Hae-Young; Klauss, Volker; Schiele, Thomas M. // Current Pharmaceutical Design;Feb2005, Vol. 11 Issue 4, p421 

    In-stent restenosis remains the limitation of coronary stent implantation despite numerous efforts of its prevention by catheter-based techniques or by drug therapy. Today, only intravascular irradiation has proven to effectively reduce neointima formation, restenosis rate and major adverse...

  • Fondaparinux. Tan, Kiat T.; Lip, Gregory Y. H. // Current Pharmaceutical Design;Feb2005, Vol. 11 Issue 4, p415 

    Fondaparinux is the first drug from the pentassaccharide factor X inhibitor class of anticoagulants to be approved for clinical use. It has been shown to be effective in the prevention of deep vein thrombosis in patients undergoing major orthopaedic surgery of the lower limbs. The drug is also...

  • FDA APPROVES EXPANSION OF CSI OASIS CLINICAL TRIAL.  // Biotech Equipment Update;Sep2006, p3 

    The article discusses the approval of Food and Drugs Administration (FDA) of the Oasis clinical trial. Cardiovascular Systems, Inc. (CSI), St. Paul announced this development. This trial, supported by the CSI, is conducted to obtain safety and effectiveness data on the Orbital Atheroctomy System...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics